Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources
News and Community
About us

Pierre Fabre Australia Pty Ltd

Regulatory activities for this sponsor.

Loading...

ARTG (39) ARTG (39)
Cancellation by sponsor (16) Cancellation by sponsor (16)
Prescription medicine registration (3)
Australian Public Assessment Report (AusPAR) (1)
Designation or determination (1) Designation or determination (1)

2024 (4) 2024 (4)
2023 (7) 2023 (7)
2022 (10) 2022 (10)
2021 (6) 2021 (6)
2020 (10) 2020 (10)
2019 (3) 2019 (3)
2018 (2) 2018 (2)
2017 (4) 2017 (4)
2015 (4) 2015 (4)
2005 (6) 2005 (6)
2000 (2) 2000 (2)
1998 (2) 1998 (2)

Search

Sponsor content

60 result(s) found, displaying 11 to 20

Eau Thermale Avene Summer Ready Pack 2022 (392330)

15 July 2022

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Eau Thermale Avene Summer Ready Pack 2022.
AusPAR: Levomilnacipran (as hydrochloride)

13 December 2016

Australian Public Assessment Report (AusPAR)

AusPAR: Levomilnacipran (as hydrochloride)
Eau Thermale Avene Summer Ready Pack (375232)

24 September 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Eau Thermale Avene Summer Ready Pack.
Eau Thermale Avene Protect & Glow Morning Routine (354469)

8 February 2021

ARTG

Australian Register of Therapeutic Goods (ARTG) information for Eau Thermale Avene Protect & Glow Morning Routine.
Hemangiol-propranolol hydrochloride Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 100 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 100 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 50 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 50 mg capsule blister pack Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd
JONCIA milnacipran hydrochloride 25 mg capsule bottle Cancelled under Section 30(1)(c) of the Act

9 June 2022

Cancellation by sponsor

Requested by Pierre Fabre Australia Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Next page
Last page

Is there anything wrong with this page?

Help us improve this page

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control - external site
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook - external site
(formerly Twitter) - external site
Youtube - external site
Instagram - external site
LinkedIn - external site

Help us improve

We are always looking for ways to improve our website.

Provide feedback - external site

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.

Pierre Fabre Australia Pty Ltd

Type

Date

Help us improve this page